FMNL1 promotes proliferation and migration of leukemia cells

Journal of Leukocyte Biology

Volumn 94, Issue 3, 2013, Pages 503-512

  Favaro, Patricia ^a,b   Traina, Fabiola ^b   Machado Neto, João Agostinho ^b   Lazarini, Mariana ^b   Lopes, Matheus Rodrigues ^b   Pereira, João Kleber Novais ^b   Costa, Fernando Ferreira ^b   Infante, Elvira ^c   Ridley, Anne J ^c   Olalla Saad, Sara Teresinha ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cell motility; Formins; Leukemogenesis; Rac1; Transendothelial migration

Indexed keywords

FMNL1 PROTEIN; PROTEIN; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN K 562; CELL TYPE; COLONY FORMATION; DEPLETION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR GROWTH; XENOGRAFT;

CELL MOTILITY; FORMINS; LEUKEMOGENESIS; RAC1; TRANSENDOTHELIAL MIGRATION;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; HUMANS; LEUKEMIA; MICE; RAC1 GTP-BINDING PROTEIN; RNA, SMALL INTERFERING;

EID: 84883260544     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0113057     Document Type: Article

References (59)

1. Chesarone, M. A., DuPage, A. G., Goode, B. L. (2010) Unleashing formins to remodel the actin and microtubule cytoskeletons. Nat. Rev. Mol. Cell. Biol. 11, 62-74.
2. Favaro, P. M., de Souza Medina, S., Traina, F., Basseres, D. S., Costa, F. F., Saad, S. T. (2003) Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with Akt. Biochem. Biophys. Res. Commun. 311, 365-371.
3. Schuster, I. G., Busch, D. H., Eppinger, E., Kremmer, E., Milosevic, S., Hennard, C., Kuttler, C., Ellwart, J. W., Frankenberger, B., Nossner, E., Salat, C., Bogner, C., Borkhardt, A., Kolb, H. J., Krackhardt, A. M. (2007) Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 110, 2931-2939.
4. Han, Y., Eppinger, E., Schuster, I. G., Weigand, L. U., Liang, X., Kremmer, E., Peschel, C., Krackhardt, A. M. (2009) Formin-like 1 (FMNL1) is regulated by N-terminal myristoylation and induces polarized membrane blebbing. J. Biol. Chem. 284, 33409-33417.
5. Favaro, P. M., Traina, F., Vassallo, J., Brousset, P., Delsol, G., Costa, F. F., Saad, S. T. (2006) High expression of FMNL1 protein in T non-Hodgkin's lymphomas. Leuk. Res. 30, 735-738.
6. Lukk, M., Kapushesky, M., Nikkila, J., Parkinson, H., Goncalves, A., Huber, W., Ukkonen, E., Brazma, A. (2010) A global map of human gene expression. Nat. Biotechnol. 28, 322-324.
7. Chesarone, M. A., DuPage, A. G., Goode, B. L. (2010) Unleashing formins to remodel the actin and microtubule cytoskeletons. Nat. Rev. Mol. Cell Biol. 11, 62-74.
8. Esue, O., Harris, E. S., Higgs, H. N., Wirtz, D. (2008) The filamentous actin cross-linking/bundling activity of mammalian formins. J. Mol. Biol. 384, 324-334.
9. Harris, E. S., Rouiller, I., Hanein, D., Higgs, H. N. (2006) Mechanistic differences in actin bundling activity of two mammalian formins, FRL1 and mDia2. J. Biol. Chem. 281, 14383-14392.
10. Harris, E. S., Gauvin, T. J., Heimsath, E. G., Higgs, H. N. (2010) Assembly of filopodia by the formin FRL2 (FMNL3). Cytoskeleton (Hoboken) 67, 755-772.
11. Yayoshi-Yamamoto, S., Taniuchi, I., Watanabe, T. (2000) FRL, a novel formin-related protein, binds to Rac and regulates cell motility and survival of macrophages. Mol. Cell. Biol. 20, 6872-6881.
12. Seth, A., Otomo, C., Rosen, M. K. (2006) Autoinhibition regulates cellular localization and actin assembly activity of the diaphanous-related formins FRLα and mDia1. J. Cell Biol. 174, 701-713.
13. Mersich, A. T., Miller, M. R., Chkourko, H., Blystone, S. D. (2010) The formin FRL1 (FMNL1) is an essential component of macrophage podosomes. Cytoskeleton (Hoboken) 67, 573-585.
14. Gomez, T. S., Kumar, K., Medeiros, R. B., Shimizu, Y., Leibson, P. J., Billadeau, D. D. (2007) Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse. Immunity 26, 177-190.
15. Young, K. G., Copeland, J. W. (2010) Formins in cell signaling. Biochim. Biophys. Acta 1803, 183-190.
16. Mason, F. M., Heimsath, E. G., Higgs, H. N., Soderling, S. H. (2011) Bi-modal regulation of a formin by srGAP2. J. Biol. Chem. 286, 6577-6586.
17. Irons, R. D., Stillman, W. S. (1996) The process of leukemogenesis. Environ. Health Perspect. 104 (Suppl. 6), 1239-1246.
18. Ridley, A. J., Hall, A. (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399.
19. Mulloy, J. C., Cancelas, J. A., Filippi, M. D., Kalfa, T. A., Guo, F., Zheng, Y. (2010) Rho GTPases in hematopoiesis and hemopathies. Blood 115, 936-947.
20. Livak, K. J., Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(+Δ Δ C(T) method. Methods 25, 402-408.
21. Traina, F., Carvalheira, J. B., Saad, M. J., Costa, F. F., Saad, S. T. (2003) BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells. FEBS Lett. 535, 17-22.
22. Perugini, R. A., McDade, T. P., Vittimberga F. J., Jr., Duffy, A. J., Callery, M. P. (2000) Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines. J. Gastrointest. Surg. 4, 24-32.
23. Sampson, V. B., Rong, N. H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N. J., Dunn, S. P., Krueger, L. J. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67, 9762-9770.
24. Machado-Neto, J. A., Favaro, P., Lazarini, M., Costa, F. F., Olalla Saad, S. T., Traina, F. (2011) Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochim. Biophys. Acta 1813, 1404-1411.
25. Oliveira, J. C., Souza, K. K., Dias, M. M., Faria, M. C., Ropelle, E. R., Flores, M. B., Ueno, M., Velloso, L. A., Saad, S. T., Saad, M. J., Carvalheira, J. B. (2008) Antineoplastic effect of rapamycin is potentiated by inhibition of IRS-1 signaling in prostate cancer cells xenografts. J. Cancer Res. Clin. Oncol. 134, 833-839.
26. Infante, E., Heasman, S. J., Ridley, A. J. (2011) Statins inhibit T-acute lymphoblastic leukemia cell adhesion and migration through Rap1b. J. Leukoc. Biol. 89, 577-586.
27. Bhavsar, P. J., Vigorito, E., Turner, M., Ridley, A. J. (2009) Vav GEFs regulate macrophage morphology and adhesion-induced Rac and Rho activation. Exp. Cell. Res. 315, 3345-3358.
28. Stam, K., Heisterkamp, N., Reynolds F. H., Jr., Groffen, J. (1987) Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol. Cell. Biol. 7, 1955-1960.
29. Chang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., McCubrey, J. A. (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17, 590-603.
30. Spender, L. C., Inman, G. J. (2012) Phosphoinositide 3-kinase/AKT/ mTORC1/2 signaling determines sensitivity of Burkitt's lymphoma cells to BH3 mimetics. Mol. Cancer Res. 10, 347-359.
31. Dunlop, E. A., Tee, A. R. (2009) Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell. Signal. 21, 827-835.
32. Wan, X., Harkavy, B., Shen, N., Grohar, P., Helman, L. J. (2007) Rapamycin induces feedback activation of Akt signaling through an IGF-1Rdependent mechanism. Oncogene 26, 1932-1940.
33. Klejman, A., Rushen, L., Morrione, A., Slupianek, A., Skorski, T. (2002) Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571. Oncogene 21, 5868-5876.
34. Savage, D. G., Antman, K. H. (2002) Imatinib mesylate-a new oral targeted therapy. N. Engl. J. Med. 346, 683-693.
35. Sawyers, C. L. (1999) Chronic myeloid leukemia. N. Engl. J. Med. 340, 1330-1340.
36. Grundler, R., Brault, L., Gasser, C., Bullock, A. N., Dechow, T., Woetzel, S., Pogacic, V., Villa, A., Ehret, S., Berridge, G., Spoo, A., Dierks, C., Biondi, A., Knapp, S., Duyster, J., Schwaller, J. (2009) Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration. J. Exp. Med. 206, 1957-1970.
37. Pals, S. T., de Gorter, D. J., Spaargaren, M. (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110, 3102-3111.
38. Thelen, M., Stein, J. V. (2008) How chemokines invite leukocytes to dance. Nat. Immunol. 9, 953-959.
39. Reymond, N., Im, J. H., Garg, R., Vega, F. M. Borda, d'Agua, B., Riou, P., Cox, S., Valderrama, F., Muschel, R. J., Ridley, A. J. (2012) Cdc42 promotes transendothelial migration of cancer cells through β1 integrin. J. Cell Biol. 199, 653-668.
40. Pai, S. Y., Kim, C., Williams, D. A. (2010) Rac GTPases in human diseases. Dis. Markers 29, 177-187.
41. Cancelas, J. A., Lee, A. W., Prabhakar, R., Stringer, K. F., Zheng, Y., Williams, D. A. (2005) Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat. Med. 11, 886-891.
42. Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., Zheng, Y. (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101, 7618-7623.
43. Castrillon, D. H., Wasserman, S. A. (1994) Diaphanous is required for cytokinesis in Drosophila and shares domains of similarity with the products of the limb deformity gene. Development 120, 3367-3377.
44. Liu, R., Linardopoulou, E. V., Osborn, G. E., Parkhurst, S. M. (2008) Formins in development: orchestrating body plan origami. Biochim. Biophys. Acta 1803, 207-225.
45. Severson, A. F., Baillie, D. L., Bowerman, B. (2002) A formin homology protein and a profilin are required for cytokinesis and Arp2/3-independent assembly of cortical microfilaments in C. elegans. Curr. Biol. 12, 2066-2075.
46. DeWard, A. D., Eisenmann, K. M., Matheson, S. F., Alberts, A. S. (2010) The role of formins in human disease. Biochim. Biophys. Acta 1803, 226-233.
47. Bartolini, F., Gundersen, G. G. (2010) Formins and microtubules. Biochim. Biophys. Acta 1803, 164-173.
48. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., Testori, A., Larue, L., Goding, C. R. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439.
49. Zhu, X. L., Zeng, Y. F., Guan, J., Li, Y. F., Deng, Y. J., Bian, X. W., Ding, Y. Q., Liang, L. (2011) FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. J. Pathol. 224, 377-388.
50. Fang, G., Kim, C. N., Perkins, C. L., Ramadevi, N., Winton, E., Wittmann, S., Bhalla, K. N. (2000) CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 96, 2246-2253.
51. Jordan, M. A., Wilson, L. (2004) Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265.
52. Cancelas, J. A., Williams, D. A. (2009) Rho GTPases in hematopoietic stem cell functions. Curr. Opin. Hematol. 16, 249-254.
53. Muller, L. U., Schore, R. J., Zheng, Y., Thomas, E. K., Kim, M. O., Cancelas, J. A., Gu, Y., Williams, D. A. (2008) Rac guanosine triphosphatases represent a potential target in AML. Leukemia 22, 1803-1806.
54. Somervaille, T. C., Cleary, M. L. (2006) Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257-268.
55. Thomas, E. K., Cancelas, J. A., Chae, H. D., Cox, A. D., Keller, P. J., Perrotti, D., Neviani, P., Druker, B. J., Setchell, K. D., Zheng, Y., Harris, C. E., Williams, D. A. (2007) Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 12, 467-478.
56. Cernuda-Morollon, E., Millan, J., Shipman, M., Marelli-Berg, F. M., Ridley, A. J. (2010) Rac activation by the T-cell receptor inhibits T cell migration. PLoS One 5, e12393.
57. Freret, M., Gouel, F., Buquet, C., Legrand, E., Vannier, J. P., Vasse, M., Dubus, I. (2011) Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1α (CXCL12). Leuk. Res. 35, 971-973.
58. Guo, S., Bao, S. (2010) srGAP2 arginine methylation regulates cell migration and cell spreading through promoting dimerization. J. Biol. Chem. 285, 35133-35141.
59. Guerrier, S., Coutinho-Budd, J., Sassa, T., Gresset, A., Jordan, N. V., Chen, K., Jin, W. L., Frost, A., Polleux, F. (2009) The F-BAR domain of srGAP2 induces membrane protrusions required for neuronal migration and morphogenesis. Cell 138, 990-1004.